0001415889-24-015475.txt : 20240604
0001415889-24-015475.hdr.sgml : 20240604
20240604184845
ACCESSION NUMBER: 0001415889-24-015475
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240604
DATE AS OF CHANGE: 20240604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kunkel Lori Anne
CENTRAL INDEX KEY: 0001536368
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 241020078
MAIL ADDRESS:
STREET 1: C/O PHARMACYCLICS, INC.
STREET 2: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001796280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 471787157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 388-5600
MAIL ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-06042024_100642.xml
X0508
4
2024-06-03
0001796280
Oric Pharmaceuticals, Inc.
ORIC
0001536368
Kunkel Lori Anne
C/O ORIC PHARMACEUTICALS, INC.
240 EAST GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Common Stock
2024-06-03
4
M
0
20500
3.75
A
20500
D
Stock Option (right to buy)
3.75
2024-06-03
4
M
0
20500
0
D
2032-06-16
Common Stock
20500
33200
D
(A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022.
/s/ Christian Kuhlen, attorney-in-fact
2024-06-04